Largest Drug Manufacturers - General Companies by Market Cap
The Drug Manufacturers - General sector has 87 publicly listed stocks with a combined market cap of $7.30 Trillion. Eli Lilly and Company leads the sector with a market cap of $1.04 Trillion. This ranking covers all Drug Manufacturers - General stocks globally — from large-cap industry leaders to mid-cap and small-cap companies — ranked by market capitalization and updated daily.
Total Market Cap (USD)
$7.30 Trillion
Companies Listed
87
Largest Company
Eli Lilly and …
| Rank | Company | Market Cap (USD) | Market Cap (Local) | Country | Price | 24h Change | 7d Change | 24h Volume |
|---|---|---|---|---|---|---|---|---|
| 1 |
Eli Lilly and Company
NYSE:LLY |
$1.04 Trillion | $1.04 Trillion | USA | $1164.89 | +1.04% | +4.41% | 57.87 Million |
| 2 |
Eli Lilly and Company
SA:LILY34 |
$853.51 Billion | R$4.35 Trillion | Brazil | R$153.70 | +0.70% | -0.16% | 250.45K |
| 3 |
Johnson & Johnson
NYSE:JNJ |
$574.95 Billion | $574.95 Billion | USA | $269.47 | -0.19% | +1.46% | 152.36 Million |
| 4 |
AbbVie Inc
NYSE:ABBV |
$356.49 Billion | $356.49 Billion | USA | $264.48 | +0.20% | +2.86% | 103.51 Million |
| 5 |
Merck & Company Inc
NYSE:MRK |
$316.95 Billion | $316.95 Billion | USA | $149.50 | +1.79% | +3.87% | 279.00 Million |
| 6 |
AstraZeneca PLC
MX:AZNN |
$290.50 Billion | MX$5.05 Trillion | Mexico | MX$1628.00 | +1.25% | -4.81% | 6.50K |
| 7 |
AstraZeneca PLC
NASDAQ:AZN |
$282.04 Billion | $282.04 Billion | USA | $187.03 | -1.43% | +1.12% | 43.91 Million |
| 8 |
Novartis AG ADR
NYSE:NVS |
$281.41 Billion | $281.41 Billion | USA | $147.48 | +0.11% | -3.02% | 34.68 Million |
| 9 |
Novartis AG
MX:NVSN |
$268.38 Billion | MX$4.66 Trillion | Mexico | MX$2444.00 | +0.99% | -11.61% | 1.06K |
| 10 |
Roche Holding AG
SW:ROG |
$256.43 Billion | CHF202.83 Billion | Switzerland | CHF320.70 | +0.79% | -8.76% | 28.40 Million |
| 11 |
AstraZeneca PLC
F:ZEGA |
$252.57 Billion | €216.04 Billion | Germany | €75.50 | -3.82% | -2.58% | 3.45K |
| 12 |
Roche Holding AG
SW:ROP |
$250.86 Billion | CHF198.42 Billion | Switzerland | CHF364.80 | +2.24% | +5.98% | 24.32 Million |
| 13 |
AstraZeneca PLC
NYSE:AZN |
$248.41 Billion | $248.41 Billion | USA | $168.10 | +1.22% | +4.95% | 75.75 Million |
| 14 |
Novartis AG
SW:NOVN |
$216.30 Billion | CHF171.09 Billion | Switzerland | CHF116.14 | +0.90% | +3.66% | 80.14 Million |
| 15 |
Amgen Inc
NASDAQ:AMGN |
$198.99 Billion | $198.99 Billion | USA | $393.16 | +1.95% | +4.19% | 68.43 Million |
| 16 |
Gilead Sciences Inc
NASDAQ:GILD |
$182.68 Billion | $182.68 Billion | USA | $150.56 | +0.30% | +4.76% | 141.77 Million |
| 17 |
Pfizer Inc
NYSE:PFE |
$151.73 Billion | $151.73 Billion | USA | $27.74 | +0.29% | +0.07% | 824.24 Million |
| 18 |
Pfizer Inc
SA:PFIZ34 |
$147.67 Billion | R$752.56 Billion | Brazil | R$33.09 | -0.78% | -2.25% | 179.03K |
| 19 |
Novo Nordisk A/S
CO:NOVO-B |
$137.16 Billion | Dkr876.68 Billion | Denmark | Dkr260.00 | -7.65% | -5.95% | 111.26 Million |
| 20 |
Bristol-Myers Squibb Company
NYSE:BMY |
$127.91 Billion | $127.91 Billion | USA | $62.62 | -0.70% | -1.60% | 219.31 Million |
| 21 |
GlaxoSmithKline PLC ADR
NYSE:GSK |
$111.15 Billion | $111.15 Billion | USA | $55.63 | -0.13% | -3.77% | 93.36 Million |
| 22 |
Sanofi
F:SNW2 |
$104.50 Billion | €89.39 Billion | Germany | €36.80 | -0.54% | +0.55% | 250.00 |
| 23 |
GSK PLC SP. ADR/2 NEW
F:GS70 |
$101.34 Billion | €86.68 Billion | Germany | €47.20 | +0.00% | -3.28% | 120.00 |
| 24 |
GlaxoSmithKline plc
MX:GSKN |
$100.93 Billion | MX$1.75 Trillion | Mexico | MX$874.00 | +1.16% | -5.21% | 3.64K |
| 25 |
Sanofi
MX:SNYN |
$100.25 Billion | MX$1.74 Trillion | Mexico | MX$727.00 | -0.82% | -2.59% | 10.57K |
| 26 |
Sanofi SA
PA:SAN |
$95.70 Billion | €81.86 Billion | France | €74.59 | +0.73% | +1.82% | 41.97 Million |
| 27 |
Roche Holding AG
SW:RO |
$50.34 Billion | CHF39.82 Billion | Switzerland | CHF373.20 | +2.30% | +5.84% | 776.67K |
| 28 |
Bayer AG NA
XETRA:BAYN |
$36.43 Billion | €31.16 Billion | Germany | €49.03 | +1.95% | +1.79% | 48.68 Million |
| 29 |
Biogen Inc
NASDAQ:BIIB |
$31.14 Billion | $31.14 Billion | USA | $219.07 | +1.66% | +3.96% | 19.35 Million |
| 30 |
ASTELLAS PHARMA UNSP.ADR
F:YPHA |
$19.55 Billion | €16.72 Billion | Germany | €12.90 | +0.00% | -3.73% | 2.40K |
| 31 |
CSPC PHARMACEUT.GR. ADR4
F:CVGU |
$11.04 Billion | €9.44 Billion | Germany | €3.52 | +0.00% | -6.38% | 45.00 |
| 32 |
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SHG:600436 |
$10.68 Billion | CN¥73.01 Billion | China | CN¥121.02 | +2.29% | +1.08% | 63.89 Million |
| 33 |
CSPC Pharmaceutical Group Limited
F:CVG |
$10.04 Billion | €8.59 Billion | Germany | €1.04 | +6.29% | +7.89% | 36.88K |
| 34 |
Sichuan Kelun Pharmaceutical Co Ltd
SHE:002422 |
$9.89 Billion | CN¥67.58 Billion | China | CN¥42.48 | +6.81% | +7.95% | 510.14 Million |
| 35 |
Orion Oyj B
HE:ORNBV |
$8.48 Billion | €7.25 Billion | Finland | €82.85 | +1.66% | +5.68% | 3.65 Million |
| 36 |
ORION CORP.B UNSP.ADR 1/2
F:OFK0 |
$8.31 Billion | €7.10 Billion | Germany | €36.20 | -1.09% | -0.55% | 40.00 |
| 37 |
GlaxoSmithKline Pharmaceuticals Limited
NSE:GLAXO |
$5.25 Billion | Rs484.99 Billion | India | Rs2862.90 | +0.85% | +0.77% | 4.05 Million |
| 38 |
Grifols S.A.
MC:GRF |
$4.73 Billion | €4.05 Billion | Spain | €9.59 | +0.48% | -2.38% | 27.82 Million |
| 39 |
Grifols S.A
F:G0FB |
$4.42 Billion | €3.78 Billion | Germany | €6.30 | +0.80% | -3.08% | 0.00 |
| 40 |
GRIFOLS ADR 1/2/EO-50
F:G0F |
$4.21 Billion | €3.60 Billion | Germany | €4.26 | -2.74% | -1.84% | 192.00 |
| 41 |
Organon & Co
NYSE:OGN |
$3.57 Billion | $3.57 Billion | USA | $13.68 | +0.00% | +0.29% | 74.82 Million |
| 42 |
Orion Oyj A
HE:ORNAV |
$3.08 Billion | €2.63 Billion | Finland | €82.70 | +1.60% | +5.75% | 105.16K |
| 43 |
Virbac SA
PA:VIRP |
$3.01 Billion | €2.58 Billion | France | €307.50 | -0.97% | -1.28% | 123.41K |
| 44 |
AstraZeneca PLC
LSE:AZN |
$2.37 Billion | GBX19.48 Trillion | UK | GBX12560.00 | +0.48% | +7.28% | 72.88 Million |
| 45 |
Pfizer Limited
NSE:PFIZER |
$2.00 Billion | Rs184.62 Billion | India | Rs4035.70 | +0.83% | -1.46% | 1.68 Million |
| 46 |
Kalbe Farma Tbk PT
JK:KLBF |
$1.99 Billion | Rp33.94 Trillion | Indonesia | Rp750.00 | -1.32% | +2.04% | 1.89 Billion |
| 47 |
Yifan Xinfu Pharmaceutical Co Ltd
SHE:002019 |
$1.71 Billion | CN¥11.71 Billion | China | CN¥9.63 | +2.77% | +4.67% | 255.82 Million |
| 48 |
Zhejiang Wolwo Bio-Pharmaceutical Co Ltd
SHE:300357 |
$1.55 Billion | CN¥10.57 Billion | China | CN¥20.19 | +3.80% | +6.38% | 285.06 Million |
| 49 |
Aurora Optoelectronics Co Ltd
SHG:600666 |
$1.42 Billion | CN¥9.71 Billion | China | CN¥3.53 | -0.28% | +3.22% | 2.58 Billion |
| 50 |
Zhejiang Jolly Pharmaceutical Co Ltd
SHE:300181 |
$1.39 Billion | CN¥9.48 Billion | China | CN¥13.52 | +1.65% | +2.66% | 313.76 Million |
| 51 |
COSMO Pharmaceuticals SA
SW:COPN |
$1.27 Billion | CHF1.01 Billion | Switzerland | CHF58.70 | -2.17% | -3.61% | 790.28K |
| 52 |
GuangYuYuan Chinese Herbal Medicine Co Ltd
SHG:600771 |
$999.93 Million | CN¥6.83 Billion | China | CN¥13.96 | +1.75% | +3.41% | 163.84 Million |
| 53 |
SANOFI CONS HEALTHC IND L
NSE:SANOFICONR |
$995.67 Million | Rs92.07 Billion | India | Rs3997.60 | -0.89% | -2.25% | 111.97K |
| 54 |
Cosmo Pharmaceuticals N.V
F:C43 |
$993.61 Million | €849.89 Million | Germany | €58.20 | -1.36% | +0.17% | 862.00 |
| 55 |
NanJing Pharmaceutical Co Ltd
SHG:600713 |
$973.01 Million | CN¥6.65 Billion | China | CN¥5.08 | +0.99% | -1.93% | 265.13 Million |
| 56 |
GlaxoSmithKline PLC
LSE:GSK |
$933.94 Million | GBX7.68 Trillion | UK | GBX1911.00 | +1.78% | +7.94% | 130.86 Million |
| 57 |
Chongqing Lummy Pharmaceutical
SHE:300006 |
$851.37 Million | CN¥5.82 Billion | China | CN¥5.51 | +4.95% | +7.62% | 1.09 Billion |
| 58 |
Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd.
SHE:301096 |
$846.33 Million | CN¥5.78 Billion | China | CN¥52.95 | +0.51% | +10.13% | 77.54 Million |
| 59 |
Shandong Keyuan Pharmaceutical Co. Ltd. A
SHE:301281 |
$816.08 Million | CN¥5.58 Billion | China | CN¥51.50 | +1.96% | +10.90% | 63.88 Million |
| 60 |
Hunan Jingfeng Pharmaceutical
SHE:000908 |
$798.18 Million | CN¥5.45 Billion | China | CN¥6.20 | +1.31% | -0.64% | 328.61 Million |
| 61 |
Zhejiang Int'L Group Co Ltd
SHE:000411 |
$769.04 Million | CN¥5.26 Billion | China | CN¥10.07 | +1.72% | +2.76% | 84.50 Million |
| 62 |
Sanofi India Limited
NSE:SANOFI |
$766.46 Million | Rs70.87 Billion | India | Rs3077.30 | -0.33% | -0.92% | 417.15K |
| 63 |
SENORES PHARMACEUTICALS L
NSE:SENORES |
$694.83 Million | Rs64.25 Billion | India | Rs1395.10 | -0.53% | -4.65% | 5.35 Million |
| 64 |
Hangzhou Minsheng Healthcare Co Ltd
SHE:301507 |
$675.15 Million | CN¥4.61 Billion | China | CN¥12.94 | +8.38% | +10.41% | 88.92 Million |
| 65 |
Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A
SHG:600613 |
$648.79 Million | CN¥4.43 Billion | China | CN¥9.25 | +9.99% | +14.20% | 2.68 Billion |
| 66 |
Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd
SHG:600671 |
$424.83 Million | CN¥2.90 Billion | China | CN¥23.84 | +5.44% | +5.86% | 81.38 Million |
| 67 |
Dimed S.A. Distribuidora de Medicamentos
SA:PNVL3 |
$388.07 Million | R$1.98 Billion | Brazil | R$13.24 | +1.30% | +2.32% | 16.20 Million |
| 68 |
Zhejiang Zhenyuan Share Co Ltd
SHE:000705 |
$351.54 Million | CN¥2.40 Billion | China | CN¥7.19 | +4.05% | +2.13% | 132.94 Million |
| 69 |
Hubei Guangji Pharmaceutical Co Ltd
SHE:000952 |
$339.78 Million | CN¥2.32 Billion | China | CN¥6.75 | +5.47% | +5.14% | 154.79 Million |
| 70 |
Amarin Corporation PLC
NASDAQ:AMRN |
$282.66 Million | $282.66 Million | USA | $13.48 | -1.10% | -2.32% | 1.84 Million |
| 71 |
Guangdong Jiaying Pharmaceutical Co Ltd
SHE:002198 |
$276.26 Million | CN¥1.89 Billion | China | CN¥3.72 | +1.64% | +2.48% | 159.02 Million |
| 72 |
NGL Fine-Chem Limited
NSE:NGLFINE |
$182.51 Million | Rs16.88 Billion | India | Rs2731.60 | -1.32% | +0.22% | 365.49K |
| 73 |
TTK Healthcare Limited
NSE:TTKHLTCARE |
$164.02 Million | Rs15.17 Billion | India | Rs1073.30 | +2.22% | -5.39% | 1.21 Million |
| 74 |
Daishin Balance No.6 Special Purpose Acquisition Co. Ltd
KQ:307750 |
$78.38 Million | ₩115.66 Billion | Korea | ₩2305.00 | -1.71% | +2.67% | 8.45 Million |
| 75 |
PharmGen Science Inc
KO:004720 |
$42.25 Million | ₩62.34 Billion | Korea | ₩2845.00 | -0.18% | -5.95% | 399.37K |
| 76 |
MIRA Pharmaceuticals, Inc. Common Stock
NASDAQ:MIRA |
$36.81 Million | $36.81 Million | USA | $0.88 | +5.65% | +13.57% | 32.36 Million |
| 77 |
Scilex Holding Company
NASDAQ:SCLX |
$36.30 Million | $36.30 Million | USA | $5.16 | +2.38% | +2.99% | 951.85K |
| 78 |
Singbao International Co Ltd
TWO:6130 |
$35.39 Million | NT$1.12 Billion | Taiwan | NT$23.75 | -0.42% | -0.63% | 2.61 Million |
| 79 |
Nasus Pharma Ltd.
NYSE MKT:NSRX |
$33.96 Million | $33.96 Million | USA | $2.90 | +1.05% | -2.36% | 2.69 Million |
| 80 |
Yung Zip Chemical Ind Co Ltd
TWO:4102 |
$25.17 Million | NT$798.75 Million | Taiwan | NT$18.85 | +0.27% | +0.53% | 494.69K |
| 81 |
Korean Drug Co. Ltd
KQ:014570 |
$25.05 Million | ₩36.97 Billion | Korea | ₩3415.00 | +0.00% | +0.74% | 101.23K |
| 82 |
Shanghai Shenqi Pharmaceutical Investment Management Co Ltd B
SHG:900904 |
$25.02 Million | $25.02 Million | China | $0.46 | +3.39% | +4.58% | 11.01 Million |
| 83 |
BCWORLD PHARM. Co. Ltd
KQ:200780 |
$20.54 Million | ₩30.31 Billion | Korea | ₩2965.00 | -1.00% | -2.47% | 174.06K |
| 84 |
Lipidor Ab
ST:LIPI |
$18.82 Million | Skr174.88 Million | Sweden | Skr0.22 | +0.00% | +0.00% | 0.00 |
| 85 |
Chorokbaem Healthcare Co Ltd
KO:118000 |
$15.06 Million | ₩22.23 Billion | Korea | ₩1294.00 | -1.97% | -2.56% | 507.12K |
| 86 |
Medicus Pharma Ltd. Common Stock
NASDAQ:MDCX |
$10.20 Million | $10.20 Million | USA | $0.17 | +0.59% | +4.91% | 205.99 Million |
| 87 |
Firebrick Pharma Ltd
AU:FRE |
$5.69 Million | AU$8.04 Million | Australia | AU$0.03 | +0.00% | -6.67% | 1.97 Million |
Track real-time market capitalization of largest public companies in the Drug Manufacturers - General industry. Compare marketcap, analyze stock performance, and discover leading drug manufacturers - general corporations. View all industries